Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 7051-7060 of 13616

Page
per page
  1. UNC2025 HCl
    C9085 UNC2025 HCl
    Summary: An ATP-competitive MERTK/FLT3 inhibitor suitable for in vitro and in vivo mechanistic studies.
      ≥25.15 mg/mL
  2. Monobenzone
    A8478 Monobenzone
    Summary: Skin depigmenting agent
  3. Thiabendazole
    A8536 Thiabendazole
    Summary: Fungicide
      insoluble in H2O; insoluble in EtOH; ≥20.09 mg/mL
  4. PX 866
    C3271 PX 866
    Summary: PI3K inhibitor
      ≤25 mg/mL
  5. Losartan Carboxaldehyde
    C3539 Losartan Carboxaldehyde
    Summary: inhibits endothelial cyclooxygenase (COX)-2 expression
      ≤30 mg/mL
  6. UNC 3230
    B4941 UNC 3230
    Summary: PIP5K1C inhibitor
      insoluble in EtOH; insoluble in H2O; ≥54.8 mg/mL
  7. Eletriptan HBr
    B2237 Eletriptan HBr
    Summary: selective 5-HT1B and 5-HT1D receptor agonist
      ≥23.17 mg/mL
  8. Tigecycline hydrochloride
    B1219 Tigecycline hydrochloride
    Summary: First-in-class, broad spectrum antibiotic
      Soluble in DMSO
  9. Terazosin HCl
    B1365 Terazosin HCl
    Summary: Selective α1-adrenoceptor antagonist
      ≥23.0 mg/mL
  10. S-Nitroso-N-acetyl-DL-penicillamine
    A4621 S-Nitroso-N-acetyl-DL-penicillamine
    Summary: An S-nitrosothiol nitric oxide (NO) donor that releases NO stably and activates cGMP signaling for vasodilation and platelet aggregation
      ≥27.7 mg/mL

Items 7051-7060 of 13616

Page
per page